Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 7 Uterine Cervical Neoplasms 6 Breast Neoplasms 6 Uterine Cervical Dysplasia 5 Persistent Infection 4 Melanoma 4 Sarcoma 2 Neuroblastoma 2 Lung Neoplasms 2 Influenza, Human 2 HIV Infections 2 Glioma 2 Glioblastoma 2 Condylomata Acuminata 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Rheumatic Diseases 1 Recurrence 1 Psoriasis 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Nerve Tissue 1

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡